Tag: manufacturing
-
Start-Up to Engineer T-Cells for Autoimmune Diseases
GentiBio Inc., a new enterprise in Boston, is starting work on creating engineered T-cells from the immune system to treat autoimmune diseases.
-
Gene Therapy Production Company Opens, Raises $40M
A new enterprise developing and manufacturing gene therapies, both its own and for others, is underway, raising $40 million in venture funds.
-
Investment Funds Named for Underserved Entrepreneurs
A foundation project identified its first five investment funds providing capital for start-up businesses founded by people usually overlooked by venture investors.
-
Challenge Seeks Next-Generation Face Mask
A challenge competition with a total purse of $1 million seeks a new type of face mask that people will be eager to wear to protect against infectious diseases.
-
BARDA to Buy $2B in Covid-19 Vaccines, Therapies
The federal health preparedness agency is spending more than $2 billion for developers to produce Covid-19 vaccines and treatments now in clinical trials.
-
Gene, Cell Therapy Start-Up Gains $700M in Early Funds
A biotechnology company creating engineered cells with modified genes for treating disease is raising $700 million in its first venture finance round.
-
Open-Source N95 Respirator Mask in the Works
An engineering partnership is designing a 3-D printed medical face mask needed by front-line health care workers, with its specifications soon to be made freely available.
-
Covid-19 Antibody Therapy Trial Underway
A clinical trial of neutralizing antibodies to treat Covid-19 infections began testing the therapy with hospitalized patients in New York and Los Angeles.
-
Drug Maker Licenses Low-Dose Vaccine Patch
The pharmaceutical company Merck is licensing a microneedle patch device that delivers vaccines with a small fraction of the dose normally needed by syringes.
-
Infographic – Largest Ever U.S. Manufacturing Decline
The Federal Reserve, the U.S. central bank, released statistics showing in April 2020, manufacturing output dropped 13.7 percent from March.